Pathology and function of nuclear amyloid: Protein homeostasis matters

Nucleus (United States)

Volumn 5, Issue 4, 2014, Pages

  von Mikecz, Anna ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

Aging; Amyloid; Congo red; Fibrillation; Huntington disease; Neurodegeneration; Nuclear inclusions; Nucleus; PolyQ; Prion disease; Protein aggregation

Indexed keywords

AMINO ACID; AMYLOID; ANDROGEN RECEPTOR; ATAXIN 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; MELANOCYTE PROTEIN PMEL 17; NUCLEAR MITOTIC APPARATUS PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEIN; PROTEIN MDM2; PROTEIN P53; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR SP1; UBIQUITIN; UNCLASSIFIED DRUG;

AGING; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; DEGENERATIVE DISEASE; HUMAN; NERVE CELL; PATHOLOGY; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; REVIEW; BIOLOGICAL MODEL; METABOLISM; PHYSIOLOGY;

AGING; AMYLOID; CELL NUCLEUS; HUMANS; INTRANUCLEAR INCLUSION BODIES; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES;

EID: 84903975397     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.29404     Document Type: Review

References (82)

1. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333-66; PMID:16756495; http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901
2. Schwartz AL, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 2009; 49:73-96; PMID:18834306; http://dx.doi.org/10.1146/annurev.pharmtox.051208.165340
3. Prusiner SB. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 2013; 47:601-23; PMID:24274755; http://dx.doi.org/10.1146/annurev-genet-110711-155524
4. Holdorff B, Rodrigues e Silva AM, Dodel R. Centenary of Lewy bodies (1912-2012). J Neural Transm 2013; 120:509-16; PMID:23456291; http://dx.doi.org/10.1007/s00702-013-0984-2
5. Beitz JM. Parkinson's disease: a review. [Schol Ed]. Front Biosci (Schol Ed) 2014; 6:65-74; PMID:24389262; http://dx.doi.org/10.2741/S415
6. Wanker EE. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol Chem 2000; 381:937-42; PMID: 11076024; http://dx.doi.org/10.1515/BC.2000.114
7. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10:83-98; PMID:21163446; http://dx.doi.org/10.1016/S1474-4422(10)70245-3
8. Vonsatt e l JP. Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115:55-69; PMID:17978822; http://dx.doi.org/10.1007/s00401-007-0306-6
9. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003; 426:895-9; PMID:14685250; http://dx.doi.org/10.1038/nature02263
10. Chen M, Singer L, Scharf A, von Mikecz A. Nuclear polyglutamine-containing protein aggregates as active proteolytic centers. J Cell Biol 2008; 180:697-704; PMID:18283109; http://dx.doi.org/10.1083/jcb.200708131
11. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Fink-beiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431:805-10; PMID:15483602; http://dx.doi.org/10.1038/nature02998
12. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007; 30:575-621; PMID:17417937; http://dx.doi.org/10.1146/annurev.neuro.29.051605.113042
13. Williams AJ, Paulson HL. Polyglutamine neurodege-neration: protein misfolding revisited. Trend s Neur-osci 2008; 31:521-8; PMID:18778858; http://dx.doi.org/10.1016/j.tins.2008.07.004
14. von Mikecz A. PolyQ fibrillation in the cell nucleus: who's bad? Trends Cell Biol 2009; 19:685-91; PMID:19796946; http://dx.doi.org/10.1016/j.tcb.2009.09.001
15. Olzscha H, Schermann SM, Woerner AC, Pinkert S, Hecht MH, Ta r t aglia GG, Vendruscolo M, Hayer-Hartl M, Hartl FU, Vabulas RM. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 2011; 144:67-78; PMID:21215370; http://dx.doi.org/10.1016/j.cell.2010.11.050
16. Schaefer MH, Wanker EE, Andrade-Navarro MA. Evolution and function of CAG/polygluta-mine repeats in protein-protein interaction networks. Nucleic Acids Res 2012; 40:4273-87; PMID:22287626; http://dx.doi.org/10.1093/nar/gks011
17. O'Nuallain B, Wetzel R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A 2002; 99:1485-90; PMID:11818542; http://dx.doi.org/10.1073/pnas.022662599
18. Wiesehan K, Buder K, Linke R P, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display. Chembiochem 2003; 4:748-53; PMID:12898626; http://dx.doi.org/10.1002/cbic.200300631
19. Marshall KE, Serpell LC. Structural integrity of beta-sheet assembly. Biochem Soc Trans 2009; 37:671-6; PMID:19614573; http://dx.doi.org/10.1042/BST0370671
20. Butterfield S, Hejjaoui M, Fauvet B, Awad L, Lashuel HA. Chemical strategies for controlling protein folding and elucidating the molecular mechanisms of amyloid formation and toxicity. J Mol Biol 2012; 421:204-36; PMID:22342932; http://dx.doi.org/10.1016/j.jmb.2012.01.051
21. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5:15-22; PMID: 19088715; http://dx.doi.org/10.1038/nchembio.131
22. Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001; 276:44284-96; PMID: 11553 618; http://dx.doi.org/10.1074/jbc.M105343200
23. Linse S, Cabaleiro-Lago C, Xue WF, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA. Nucleation of protein fibrillation by nanopar-ticles. Proc Natl Acad Sci U S A 2007; 104:8691-6; PMID:17485668; http://dx.doi.org/10.1073/pnas.0701250104
24. Arnhold F, von Mikecz A. Quantitative feature extraction reveals the status quo of protein fibrillation in the cell nucleus. Integr Biol (Camb) 2011; 3:761-9; PMID:21687851; http://dx.doi.org/10.1039/c0ib00146e
25. Scharf A, Piechulek A, von Mikecz A. Effect of nanopar ticles on the biochemical and behavioral aging phenotype of the nematode Caenorhabditis elegans. ACS Nano 2013; 7:10695-703; PMID:24256469; http://dx.doi.org/10.1021/nn403443r
26. Jack CR Jr., Holtzman DM. Biomarker modeling of Alzheimer's disease. Neuron 2013; 80:1347-58; PMID:24360540; http://dx.doi.org/10.1016/j.neuron.2013.12.003
27. Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, Finkbeiner S, Patterson PH, Muchowski PJ. Monoclonal antibodies recognize distinct conforma-tional epitopes formed by polyglutamine in a mutant huntingtin fragment. J Biol Chem 2009; 284:21647-58; PMID:19491400; http://dx.doi.org/10.1074/jbc.M109.016923
28. Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 2009; 4:673-84; PMID:19624097; http://dx.doi.org/10.1021/cb900112v
29. Vonsattel JP, Keller C, Cortes Ramirez EP. Hunting-ton's disease- neuropathology. Handb Clin Neurol 2011; 100:83-100; PMID:21496571; http://dx.doi.org/10.1016/B978-0-444-52014-2.00004-5
30. Yamada M, Sato T, Tsuji S, Takahashi H. CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115:71-86; PMID:17786 457; http://dx.doi.org/10.1007/s00401-007-0287-5
31. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsatt e l JP, Aronin N. Aggregation of hun-tingtin in neuronal intranuclear inclusions and dys-trophic neurites in brain. Science 1997; 277:199 0-3; PMID:9302293; http://dx.doi.org/10.1126/science.277.5334.1990
32. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90:537-48; PMID:9267033; http://dx.doi.org/10.1016/S0092-8674(00)80513-9
33. Duyckaerts C, Dürr A, Cancel G, Brice A. Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neu-ropathol 1999; 97:201-7; PMID:9928833; http://dx.doi.org/10.1007/s004010050975
34. Yamada M, Sato T, Shimohata T, Hayashi S, Iga-rashi S, Tsuji S, Takahashi H. Interaction between neuronal intranuclear inclusions and promyelo-cytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 2001; 159:1785-95; PMID:11696439; http://dx.doi.org/10.1016/S0002-9440(10)63025-8
35. Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 1998; 44:249-54; PMID:9708548; http://dx.doi.org/10.1002/ana.410440216
36. Li M, Nakagomi Y, Kobayashi Y, Merry DE, Tanaka F, Doyu M, Mitsuma T, Hashizume Y, Fischbeck KH, Sobue G. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol 1998; 153:695-701; PMID: 9736019; http://dx.doi.org/10.1016/S0002-9440(10)65612-X
37. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 1999; 19:2522-34; PMID:10087066
38. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 1998; 19:148-54; PMID:9620770; http://dx.doi.org/10.1038/502
39. Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, Rankin J, Rubinsztein DC. Effects of heat shock, heat shock protein 40 (HDJ-2), and pro-teasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A 2000; 97:2898-903; PMID:10717003; http://dx.doi.org/10.1073/pnas.97.6.2898
40. Abel A, Walcott J, Woods J, Duda J, Merry DE. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum Mol Genet 2001; 10:107-16; PMID:11152658; http://dx.doi.org/10.1093/hmg/10.2.107
41. Jana NR, Zemskov EA, Wa ng Gh, Nukina N. Altered proteasomal function due to the expression of poly-glutamine-expanded truncated N-terminal hunting-tin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 2001; 10:1049-59; PMID:11331615; http://dx.doi.org/10.1093/hmg/10.10.1049
42. Tsvetkov AS, Arrasate M, Barmada S, Ando DM, Sharma P, Shaby BA, Finkbeiner S. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat Chem Biol 2013; 9:586-92; PMID:23873212; http://dx.doi.org/10.1038/nchembio.1308
43. Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, Gage FH. Identities of sequestered proteins in aggregates from cells with induced poly-glutamine expression. J Cell Biol 2001; 153:283-94; PMID:11309410; http://dx.doi.org/10.1083/jcb.153.2.283
44. Mitsui K, Doi H, Nukina N. Proteomics of polyglu-tamine aggregates. Methods Enzymol 2006; 412:63-76; PMID:17046652; http://dx.doi.org/10.1016/S0076-6879(06)12005-4
45. Kazantsev A, Preisinger E, Dranovsky A, Goldg-aber D, Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpatho-logical lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 1999; 96:114 04-9; PMID:10500189; http://dx.doi.org/10.1073/pnas.96.20.11404
46. Nucifora FC Jr., Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Tron-coso J, Dawson VL, et al. Interference by hunting-tin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001; 291:2423-8; PMID:11264541; http://dx.doi.org/10.1126/science.1056784
47. Bithell A, Johnson R, Buckley NJ. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease. Biochem Soc Tra n s 2009; 37:1270-5; PMID:19909260; http://dx.doi.org/10.1042/BST0371270
48. Chen M, von Mikecz A. Specific inhibition of rRNA transcription and dynamic relocation of fibrillarin induced by mercury. Exp Cell Res 2000; 259:225-38; PMID:10942594; http://dx.doi.org/10.1006/excr.2000.4923
49. Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xeno-biotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum 2005; 52:877-84; PMID:15751092; http://dx.doi.org/10.1002/art.20962
50. Harada O, Hoe R, Lin J, Thike AA, Jara-Lazaro AR, Petersson F, Ta n PH. Intranuclear inclusions in epithelial cells of benign proliferative breast lesions. J Clin Pathol 2 011; 64:776-80; PMID:21606232; http://dx.doi.org/10.1136/jclinpath-2011-200094
51. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid--from bacteria to humans. Trends Bio-chem Sci 2007; 32:217-24; PMID:17412596; http://dx.doi.org/10.1016/j.tibs.2007.03.003
52. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson K P, Simon R, Schubert D, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009; 325:328-32; PMID:19541956; http://dx.doi.org/10.1126/science.1173155
53. Faux NG, Bottomley SP, Lesk AM, Irving JA, Morrison JR, de la Banda MG, Whisstock JC. Functional insights from the distribution and role of homo-peptide repeat-containing proteins. Genome Res 2005; 15:537-51; PMID: 15805494; http://dx.doi.org/10.1101/gr.3096505
54. He Y, Fang J, Ta atje s DJ, Nogales E. Structural visualization of key steps in human transcription initiation. Nature 2013; 495:481-6; PMID:23446344; http://dx.doi.org/10.1038/nature11991
55. Gerber HP, Seipel K, Georgiev O, Höfferer M, Hug M, Rusconi S, Schaffner W. Transcriptional activation modulated by homopolymeric gluta-mine and proline stretches. Science 1994; 263:808-11; PMID:8303297; http://dx.doi.org/10.1126/science.8303297
56. Landrum E, Wetzel R. Biophysical underpinnings of the repeat length dependence of polyglutamine amyloid formation. J Biol Chem 2014; 289:10254-60; PMID:24596088; http://dx.doi.org/10.1074/jbc.C114.552943
57. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in trans-genic mice. Cell 1996; 87:493-506; PMID:8898202; http://dx.doi.org/10.1016/S0092-8674(00)81369-0
58. Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2002; 99:10 417-22; PMID:12122205; http://dx.doi.org/10.1073/pnas.152161099
59. Bilen J, Bonini NM. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 2005; 39:153-71; PMID:16285856; http://dx.doi.org/10.1146/annurev.genet.39.110304.095804
60. Klein FA, Pastore A, Masino L, Zeder-Lutz G, Nieren-garten H, Oulad-Abdelghani M, Altschuh D, Mandel JL, Trottier Y. Pathogenic and non-pathogenic poly-glutamine tracts have similar structural properties: towards a length-dependent toxicity gradient. J Mol Biol 2007; 371:235-44; PMID:17560603; http://dx.doi.org/10.1016/j.jmb.2007.05.028
61. La Spada AR, Taylor JP. Polyglutamines placed into context. Neuron 2003; 38:681-4; PMID:12797953; http://dx.doi.org/10.1016/S0896-6273(03)00328-3
62. Bhattacharyya A, Thakur AK, Chellgren VM, Thiagarajan G, Williams AD, Chellgren BW, Creamer TP, Wetzel R. Oligoproline effects on poly-glutamine conformation and aggregation. J Mol Biol 2006; 355:524-35; PMID:16321399; http://dx.doi.org/10.1016/j.jmb.2005.10.053
63. Darnell G, Orgel JP, Pahl R, Meredith SC. Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J Mol Biol 2007; 374:688-704; PMID:17945257; http://dx.doi.org/10.1016/j.jmb.2007.09.023
64. Ellis RJ, Minton AP. Protein aggregation in crowded environments. Biol Chem 2006; 387:485-97; PMID:16740119; http://dx.doi.org/10.1515/BC.2006.064
65. Zhou HX, Rivas G, Minton AP. Macromo-lecular crowding and confinement: biochemical, biophysical, and potential physiological consequences. Annu Rev Biophys 2008; 37:375-97; PMID:18573087; http://dx.doi.org/10.1146/annurev.biophys.37.032807.125817
66. Hemmerich P, Schmiedeberg L, Diekmann S. Dynamic as well as stable protein interactions contribute to genome function and maintenance. Chromosome Res 2 011; 19:131-51; PMID:21046224; http://dx.doi.org/10.1007/s10577-010-9161-8
67. Hancock R. The crowded nucleus. Int Rev Cell Mol Biol 2014; 307:15-26; PMID:24380591; http://dx.doi.org/10.1016/B978-0-12-800046-5.00002-3
68. von Mikecz A. The nuclear ubiquitin-proteasome system. J Cell Sci 2006; 119:1977-84; PMID:16687735; http://dx.doi.org/10.1242/jcs.03008
69. Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, Hipp MS, Hayer-Hartl M, Hartl FU. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 2013; 154:134-45; PMID:23791384; http://dx.doi.org/10.1016/j.cell.2013.06.003
70. Uversky VN. Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics 2010; 7:543-64; PMID:20653509; http://dx.doi.org/10.1586/epr.10.36
71. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wa nker EE. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997; 90:549-58; PMID:9267034; http://dx.doi.org/10.1016/S0092-8674(00)80514-0
72. Huang CC, Faber PW, Persichetti F, Mittal V, Von-sattel JP, MacDonald ME, Gusella JF. Amyloid formation by mutant huntingtin: threshold, pro-gressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 1998; 24:217-33; PMID:10410676; http://dx.doi.org/10.1023/B:SCAM.0000007124.19463.e5
73. Palazzolo I, Nedelsky NB, Askew CE, Harmison GG, Kasantsev AG, Taylor JP, Fischbeck KH, Pen-nuto M. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. J Neurosci Res 2010; 88:2207-16; PMID:20336775; http://dx.doi.org/10.1002/jnr.22389
74. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, Orr HT. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389:971-4; PMID:9353120; http://dx.doi.org/10.1038/40153
75. Kim S, Nollen EA, Kitagawa K, Bindokas VP, Morimoto RI. Polyglutamine protein aggregates are dynamic. Nat Cell Biol 2002; 4:826-31; PMID:12360295; http://dx.doi.org/10.1038/ncb863
76. Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman N. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 1998; 143:1457-70; PMID:9852144; http://dx.doi.org/10.1083/jcb.143.6.1457
77. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polygluta-mine in TATA-binding protein. Hum Mol Genet 2001; 10:14 41-8; PMID: 11448935; http://dx.doi.org/10.1093/hmg/10.14.1441
78. Bichelmeier U, Schmidt T, Hübener J, Boy J, Rüt-tiger L, Häbig K, Poths S, Bonin M, Knipper M, Schmidt WJ, et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci 2007; 27:7418-28; PMID:17626202; http://dx.doi.org/10.1523/JNEUROSCI.4540-06.2007
79. Seidel K, den Dunnen WF, Schultz C, Paulson H, Frank S, de Vos RA, Brunt ER, Deller T, Kampinga HH, Rüb U. Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol 2010; 120:449-60; PMID:20635090; http://dx.doi.org/10.1007/s00401-010-0717-7
80. Yamada M, Wood JD, Shimohata T, Hayashi S, Tsuji S, Ross CA, Takahashi H. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 2001; 49:14-23; PMID: 11198291; http://dx.doi.org/10.1002/1531-8249(200101)49:114::AID-ANA53.0.CO;2-X
81. Janer A, Werner A, Takahashi-Fujigasaki J, Daret A, Fujigasaki H, Takada K, Duyckaerts C, Brice A, Dejean A, Sittler A. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum Mol Genet 2010; 19:181-95; PMID: 19843541; http://dx.doi.org/10.1093/hmg/ddp478
82. Hazeki N, Tsuk a moto T, Yazawa I, Koyama M, Hat-tori S, Someki I, Iwatsubo T, Nakamura K, Goto J, Kanazawa I. Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine. Biochem Biophys Res Commun 2002; 294:429-40; PMID:12051730; http://dx.doi.org/10.1016/S0006-291X(02)00498-9